Suppr超能文献

高数量的程序性细胞死亡受体 1 阳性肿瘤浸润淋巴细胞与移植后淋巴组织增生性疾病的早期发病相关。

High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.

机构信息

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871, Japan.

Department of Pathology, Kurume University School of Medicine, Kurume, Japan.

出版信息

Int J Hematol. 2021 Jul;114(1):53-64. doi: 10.1007/s12185-021-03129-3. Epub 2021 Mar 25.

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication of transplantation. In addition to reactivation of Epstein-Barr virus in immunocompromised patients, impaired tumor immunity is suggested to be a risk factor for PTLD. However, it remains unclear whether immune suppressive tumor-infiltrating lymphocytes (TILs) correlate with the occurrence or prognosis of PTLD. We analyzed TILs in 26 patients with PTLD to elucidate the clinicopathological significance of the expression of PD-1 and FoxP3, which are associated with exhausted T-cells and regulatory T-cells (Tregs), respectively. Numbers of PD-1 TILs in the PTLD specimens were significantly higher in patients who developed PTLD early after transplantation (P = 0.0040), while numbers of FoxP3 TILs were not (P = 0.184). There was no difference in overall response rate regardless of the expression of PD-1 or FoxP3. FoxP3 patients tended to have a shorter time to progression compared with FoxP3 patients, especially in the case of FoxP3 patients with diffuse large B-cell lymphoma-subtype PTLD (P = 0.011), while PD-1 patients did not. These results suggest that T-cell exhaustion may be mainly associated with PTLD development, while immune suppression by Tregs may be dominant in enhanced progression of PTLD following disease occurrence.

摘要

移植后淋巴组织增生性疾病(PTLD)是移植的一种危及生命的并发症。除了免疫功能低下患者中 EBV 的再激活外,肿瘤免疫受损被认为是 PTLD 的一个危险因素。然而,免疫抑制性肿瘤浸润淋巴细胞(TILs)是否与 PTLD 的发生或预后相关仍不清楚。我们分析了 26 例 PTLD 患者的 TILs,以阐明与耗竭性 T 细胞和调节性 T 细胞(Tregs)相关的 PD-1 和 FoxP3 的表达的临床病理意义。在移植后早期发生 PTLD 的患者的 PTLD 标本中,PD-1 TIL 的数量明显更高(P=0.0040),而 FoxP3 TIL 的数量则没有(P=0.184)。无论 PD-1 或 FoxP3 的表达如何,总缓解率均无差异。与 FoxP3 患者相比,FoxP3 患者的疾病进展时间更短,尤其是弥漫性大 B 细胞淋巴瘤亚型 PTLD 的 FoxP3 患者(P=0.011),而 PD-1 患者则没有。这些结果表明,T 细胞耗竭可能主要与 PTLD 的发展有关,而 Tregs 的免疫抑制作用可能在疾病发生后 PTLD 的进展中占主导地位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验